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Abstract
Objectives To compare self-reported levels of physical activity (PA) of systemic sclerosis (SSc) patients with the general 
population. To evaluate in SSc patients factors associated with PA levels and needs and preferences regarding PA.
Methods Fifty nine SSc patients completed the Short QUestionnaire to ASsess Health-Enhancing PA. The proportion of 
patients meeting the Dutch Recommendation for PA (= moderate PA for 30 min on ≥ 5 days/week) and total minutes of 
PA per week were calculated and compared with similar data from the Dutch population. Characteristics were univariately 
and multivariately compared between patients with low and high PA levels (either ≤ or > mean minutes/week of the Dutch 
population). Needs and preferences regarding PA promotion and guidance related to exercise were assessed by questionnaires.
Results Stratified for age (< 55 or ≥ 55 years) and gender, the proportion SSc patients meeting the Dutch recommenda-
tion for PA was not significantly different from the Dutch population. The total minutes of PA per week was significantly 
lower among SSc patients (1704 vs. 2614, P < 0.001). Multivariable analyses showed that in SSc patients the male gender, 
scleroderma health assessment questionnaire (SHAQ) and lack of energy were significantly associated with lower PA levels 
(P = 0.007; P = 0.042; P = 0.025). Two-third of patients required more information about PA.
Conclusion In SSc patients, the total minutes of PA per week are significantly lower compared to the general population. 
The male gender, functional ability as reflected by SHAQ and lack of energy seem to interfere with PA. These results might 
guide health professionals in providing their patients with appropriate information on PA.
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Introduction
Systemic sclerosis (SSc) is a rare autoimmune disease that is 
characterised by fibrosis and vasculopathy and clinically by 
Raynauds phenomenon and involvement of multiple organ 
systems, such as the gastrointestinal tract, kidneys, heart, 
lungs and musculoskeletal system. Based on the extent and 
localisation of skin involvement SSc, is subdivided into dif-
fuse cutaneous SSc and limited SSc [3].
As a result of the impact of SSc on patients’ overall health 
status, the exercise capacity of SSc patients was found to 
be limited as well [4]. Studies on exercise capacity in SSc 
patients have so far mainly focused on aerobic capacity, 
and included maximal and submaximal endurance tests [5, 
6]. However, from the patient’s perspective physical activ-
ity (PA) incorporated in a person’s daily life may be even 
more relevant. PA should be distinguished from exercise 
although the terms are often used interchangeably. PA 
includes exercise as well as other activities which involve 
bodily movement and are done as part of playing, working, 
active transportation, house chores and recreational activi-
ties. Exercise is a subcategory of physical activity that is 
planned, structured, repetitive, and purposeful in the sense 
that the improvement or maintenance of one or more com-
ponents of physical fitness is the objective [7].
Rheumatology
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Whereas in other rheumatic conditions [8], including 
rheumatoid arthritis [9], osteoarthritis [10], spondyloar-
thritis [11, 12] and systemic lupus erythematosus [13], lev-
els of PA were found to be lower than those of the general 
population, research in SSc is scarce. A recent study con-
cluded that approximately half of the SSc patients engaged 
in exercise and that these patients exercised on average 
4.7 h per week [14]. In addition, another study found that 
although SSc patients reported an overall lower capacity 
for walking, jogging and running and more limiting factors 
for physical capacity than population-based controls, there 
were no differences in reported PA and time sitting [15]. 
Moreover, daily physical activities can also be assessed 
by more objective instruments such as a portable multiple 
sensor device. This study concluded that daily physical 
activities were significantly reduced in 27 SSc patients 
as compared to 11 controls patients [15, 16]. However, to 
our knowledge no study has assessed the overall level of 
PA in minutes per week and adherence to guidelines of 
PA for patients with SSc and compared this to the general 
population. This information is relevant, as it is generally 
acknowledged that for patients with rheumatic conditions, 
regular PA does not only have general health benefits but 
has a beneficial impact on disease-related consequences 
such as pain, stiffness, and fatigue as well [17].
Together with the evaluation of SSc patient’s prefer-
ences regarding guidance to obtain and maintain a suf-
ficient level of PA, knowledge on PA levels can stimulate 
specific guidance of SSc patients in improving a healthy 
lifestyle including sufficient levels of PA and appropriate 
exercise related to their condition.
Therefore, the current study aimed to determine the 
level of PA in patients with SSc as well as factors associ-
ated with PA. We evaluated the PA levels in patients with 
SSc and compared these to the levels of the general Dutch 
population. In addition, we evaluated whether specific dis-
ease characteristics are associated with the PA levels in 
SSc patients and specific needs and preferences regarding 
PA promotion and guidance related to exercise among SSc 
patients.
Patients and methods
Study design
This analysis is part of a large prospective cohort study on 
patients with SSc participating in an annual comprehen-
sive care program [18]. This annual care program started 
in 2009 (and is still operational now, in October 2017) and 
all patients participating in this program provided writ-
ten informed consent for using gathered data for clinical 
analyses. This standardised 2-day care pathway comprises 
a visit to the rheumatologist, pulmonologist and cardi-
ologist. In addition to the extensive medical screening, 
patients are routinely seen by a physical therapist for sev-
eral measurements and advice regarding PA and exercise 
and/or referral to a first line physical therapist. For every 
patient, the care pathway is performed on 2 consecutive 
days between 8:00 and approximately 16:00. All patients, 
in whom a diagnosis of SSc is confirmed during the first 
visit to the care pathway, are included for the annual fol-
low-up. The present study was performed in a group of 59 
patients who visited an information meeting on SSc and 
the care program (September 2014). All patients attending 
the meeting were asked to fill in questionnaires specifically 
concerning levels of PA and needs for instructions to exer-
cise. Additional data concerning clinical characteristics 
and functional ability were gathered in the context of the 
prospective follow-up study.
A comparison of patients’ PA levels with those of the 
general population was made using aggregated, publicly 
available data acquired from a health survey of the Central 
Bureau for Statistics (CBS; http://statline.cbs.nl/Statweb/).
Patients
Admission criteria for the care program included a diagnosis 
of SSc according to the referring rheumatologist, or a strong 
suspicion for SSc and a request for a complete diagnostic 
work-up to confirm the diagnosis. Patients can be referred 
by rheumatologists from the outpatient clinic of the LUMC 
or from any other hospital in The Netherlands [18]. All 
included SSc patients fulfilled the criteria of the American 
College of Rheumatology 1980 or LeRoy Criteria for SSc 
and 51 (88%) fulfilled the American College of Rheumatol-
ogy 2013 criteria for SSc [19, 20].
General population
The data from the CBS are gathered annually by sending 
health questionnaires to a sample of the Dutch population. 
These surveys include measures of PA and quality of life. 
The Short QUestionnaire to ASsess Health-Enhancing PA 
(SQUASH) was used to measure levels of PA. Aggregated 
data, categorized by sex and age (categories: ≥20 years, 
20–55 years, ≥ 55  years) were obtained from the CBS 
(Appendix 1 in Electronic supplementary materials). For 
all subtotals of the SQUASH and the total SQUASH, mean 
values, standard errors of the mean, standard deviations and 
the number of respondents were provided, allowing statisti-
cal comparisons with the data from the SSc patients. For the 
present analysis, data of 2013 were used.
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Main outcome variables
Physical activity
PA was measured using the validated Dutch version of 
the Short QUestionnaire to Assess Health-Enhancing PA 
(SQUASH) [21]. The SQUASH consists of 17 items ask-
ing respondents to recall PA as performed during a regular 
week, categorized into commuting activities, activities at 
work and school, walking, cycling, household activities, 
gardening, odd jobs, leisure time activities and sport activi-
ties. Patients wrote down how many days per week and how 
many hours per day they spent performing these activities, 
which made it possible to calculate the total minutes per 
week spent on PA. With the aid of the Ainsworth compen-
dium assigning the metabolic equivalents (METS) to each 
activity [22], we then could define the intensity of the PA. 
This information was used to define if an individual adhered 
to the Dutch Recommendation for Health-Enhancing PA.
The following definition of the Dutch Recommendation 
for Health-Enhancing PA for adults aged between 18 and 
55 years was used: “at least 30 min of PA with moderate 
intensity (≥ 4 METs) on more than 5 days per week”. For 
adults aged 55 and above the Dutch Recommendation for 
Health-Enhancing PA is defined as “at least 30 min of PA 
with moderate intensity (≥ 3 METs) on more than 5 days 
per week” [23].
Needs, preferences and perceptions regarding PA 
promotion and guidance related to exercise
The patients’ perceptions on PA and their need for infor-
mation were assessed using 26 statements (Appendix 2 
in Electronic supplementary materials). Three statements 
concerned the need for more information regarding PA and 
exercise and four statements for the need for instructions 
to exercise. The other 19 statements assessed the opinions 
and knowledge of patients with SSc about PA promotion 
and guidance related to exercise. Given considerable over-
lap between part of the statements, data were summarized 
according to the subject addressed. Complete data of each 
individual statement are shown in Appendix 2 in Electronic 
supplementary materials, Table 1.
The statements were graded on a five point Likert scale, 
ranging from totally agree to totally disagree. For analyses, 
the scores were dichotomized in two categories: 0: “totally 
disagree, disagree, indifferent” and 1: “agree or totally 
agree”.
Assessments
Of all patients, sociodemographic data, disease charac-
teristics and a measure of daily functioning were obtained 
from the database of the larger cohort study. For the cur-
rent study, data gathered during the visit to the care pro-
gram closest to the date of the information meeting were 
used.
Sociodemographic characteristics included age, gender, 
origin, smoking habits and Body Mass Index (BMI, kg/m2). 
Furthermore, we checked for significant comorbidity inter-
fering with PA and exercise and not related to SSc by manu-
ally reviewing the medical records. Significant comorbidity 
included osteoarthritis resulting in joint prosthesis, limb 
amputation and cardiovascular or pulmonary comorbidity.
Disease characteristics included type of SSc (diffuse 
or limited), duration of Raynaud’s phenomenon, duration 
of non-Raynaud’s phenomenon (time since first symptom 
other than Raynaud’s phenomenon) and disease duration 
(time since diagnosis SSc was confirmed by a physician). 
The extent and severity of skin involvement was measured 
by means of the modified Rodnan Skin Score (mRSS) and 
ranged from 0 [normal] to 3 [most severe] on 17 different 
body parts combining to a total maximum score of 51 [24].
Active joint/muscle involvement was defined as the pres-
ence of proximal muscular weakness, synovitis or both. 
Muscle strength was assessed by an experienced rheuma-
tologist and graded on a 0–5 scale, patients with a score < 5 
were classified as having proximal muscle weakness. The 
presence of synovitis was assessed by an experienced rheu-
matologist [25]. The presence of joint contractures or atro-
phy was also included (yes when either joint contractures, 
atrophy or both were present). Gastrointestinal involvement 
was defined as the presence of at least one of the following 
symptoms: reflux, early satiety, vomiting, diarrhoea, intesti-
nal distension, constipation, faecal incontinence, parenteral 
nutrition or dysphagia.
The use of immunosuppressive therapy (yes/no), presence 
of anti-Scl70 antibodies (yes/no), anti-centromere antibod-
ies (yes/no) and presence of RNA polymerase III antibodies 
were collected as well.
Additionally, a 6  min walking test (total distance in 
meters) was performed. Lung functioning was assessed by 
measuring the diffusing capacity for carbon monoxide (% 
of predicted; a reduced diffusing capacity for carbon mon-
oxide was defined as < 70 [26]). Diagnosis of interstitial 
lung disease (ILD; yes/no) was determined based on the 
presence of interstitial fibrosis or ground glass opacities on 
high-resolution computerised tomography as reported by the 
radiologist.
The systolic pulmonary artery pressure and left ventricu-
lar ejection fraction were estimated using echocardiography 
by an experienced cardiologist. Elevated pulmonary pres-
sure was defined using a cut-off value of 35 mm Hg [27]. 
A decreased ejection fraction was defined as ≤ 54% [28]. 
Presence of arrhythmias was defined as presence of multi-
form ventricular extrasystoles > 100/day, couplets or runs of 
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ventricular tachycardia or supraventricular tachycardia or at 
least 30 s on 24 h Holter monitoring.
Patients were asked to fill in the Scleroderma Health 
Assessment Questionnaire (SHAQ) to measure daily func-
tioning. This is a 20-item questionnaire comprising eight 
domains of activities of daily living, with the final score 
ranging from 0 (no disability) to 3 (severe disability) [29].
Statistical analysis
For the patients’ sociodemographic and disease characteris-
tics descriptive statistics were used.
According to their distribution, continuous variables were 
either presented as mean and standard deviation (SD) or 
medians with interquartile range (p25–p75). Categorical 
variables were presented as frequencies with percentages.
To compare the characteristics of patients participat-
ing in the present analysis with the other patients taking 
part in the annual care program, Mann–Whitney U or 
Chi-square tests were used. The following characteris-
tics were compared between the included patients in this 
study and the rest of the cohort: age, gender, BMI, type of 
SSc, duration of Raynaud’s phenomenon, duration of non-
Raynaud’s phenomenon, disease duration, modified Rod-
nan skin score, proximal muscular weakness or synovitis, 
gastrointestinal involvement, anti-Scl-70 antibodies, anti-
centromere antibodies, RNA polymerase III antibodies, 
interstitial lung disease, pulmonary arterial hypertension, 
decreased ejection fraction and arrhythmia.
Comparisons of proportion of persons fulfilling the 
Dutch Recommendation for Health-Enhancing PA to the 
proportion of the Dutch population were performed with 
a logistic regression.
Comparisons of the total minutes per week spent on PA 
between SSc patients and the Dutch population were done 
by a t test. Data of the Dutch population were aggregated 
which was taken into account when using t tests.
Table 1  Characteristics of 
participating systemic sclerosis 
patients (N = 59)
a DLCO: diffuse capacity for carbon monoxide. A reduced DLCO was defined as < 70
b Gastrointestinal involvement was defined as the presence of one of the following symptoms: reflux, early 
satiety, vomiting, diarrhoea, intestinal distension, constipation, faecal incontinence, parenteral nutrition or 
dysphagia
Sociodemographic characteristics
 Age, years, median (interquartile range) 65 (55–70)
 Female, N (%) 52 (88%)
 Caucasian origin, N (%) 48 (81%)
 Smoking
  Currently, N (%) 3 (5%)
  Past, N (%) 29 (49%)
 Body mass index, kg/m2, mean (SD)a 25 (4)
Disease characteristics
 Type of systemic sclerosis, diffuse, N (%) 15 (25%)
 Duration of Raynaud’s phenomenon, years, median (interquartile range) 12 (6–22)
 Duration of non-Raynaud’s phenomenon, years, median (interquartile range) 6 (3–16)
 Disease duration, years, median (interquartile range) 4 (2–15)
 Modified Rodnan Skin Score, median (interquartile range) 3 (0–6)
 Proximal muscular weakness or synovitis, N (%) 6 (10%)
 Joint contractures or atrophy, N (%) 11 (19%)
 Gastrointestinal involvement, N (%)b 41 (76%)
 Immunotherapy, current or past, N (%) 38 (64%)
 Anti-Scl-70, N (%) 9 (15%)
 Anti-centromere, N (%) 29 (49%)
 RNA polymerase III, N (%) 3 (5%)
 6 min walking distance: total distance, mean (SD) 511 (84)
 Decrease in DLCO% of predicted, N (%)a 35 (60%)
 Interstitial lung disease according HRCT, N (%) 26 (45%)
 Pulmonary arterial hypertension, N (%) 6 (11%)
 Decreased ejection fraction, N (%) 7 (13%)
 Arrhythmia 24 (46%)
 Scleroderma health assessment questionnaire, median (interquartile range) 0.75 (0.25–1.125)
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Furthermore, percentages of SSc patients agreeing with 
the different items exploring needs, preferences and percep-
tions for the delivery of PA promotion and guidance related 
to exercise were computed.
Finally, univariate analyses of variance were performed 
for each characteristic to determine whether characteristics 
influenced the total minutes of PA. This was done for the fol-
lowing characteristics: age, gender, BMI, type of SSc, dura-
tion of Raynaud’s phenomenon, duration of non-Raynaud’s 
phenomenon, disease duration, modified Rodnan skin score, 
proximal muscular weakness or synovitis, atrophy or joint 
contractures, gastrointestinal involvement, 6 minute walk-
ing distance, reduced diffuse capacity for carbon monoxide, 
interstitial lung disease, pulmonary arterial hypertension, 
decreased ejection fraction, arrhythmia, the SHAQ, pain 
during exercise and lack of energy. Then, characteristics 
which were univariately associated with the total minutes 
of PA (p value of < 0.2) were entered in a stepwise multiple 
linear regression model.
Data entry was performed using Microsoft Office Access 
2003. All statistical analyses were executed using SPSS 23.0 
software (SPSS Inc., Chicago, USA).
Results
Seventy-nine patients attended an information meeting and 
59 (75%) completed the questionnaire on PA. The median 
duration between the information meeting and the date of 
clinical evaluation in the health care program was 145 days 
(interquartile range 76–387).
Participants
Table 1 shows the characteristics of the 59 participating SSc 
patients. These included 52 women and 7 men, ranging in 
age from 20 to 84 years (median age 65 years) with dis-
ease duration ranging from 1 month to 38 years (median 
4 years). 14 (24%) SSc patients were younger than 55 years. 
15 (25%) patients had diffuse SSc and 44 (75%) limited cuta-
neous SSc. One patient used a rollator because of walking 
problems caused by peripheral vasculopathy and thus had 
comorbidity not directly related to SSc and possibly interfer-
ing with PA.
In September 2014, the cohort of SSc patients consisted 
of 303 participants. A comparison between the included 
SSc patients (N = 59) in this study and the rest of the cohort 
(N = 244) showed that the included SSc patients were sig-
nificantly older than the rest of the cohort (65 vs. 54 years, 
P < 0.001). Additionally, the proportion of included SSc 
patients in this study positive for anti-centromere antibod-
ies was higher than the proportion of the rest of the cohort 
(51 vs. 32%, P = 0.006). No other variable was significantly 
different between both groups (Appendix 3 in Electronic 
supplementary materials).
Proportion of persons with SSc and the general 
population meeting the Dutch Recommendation 
for Health‑Enhancing PA
The proportions of SSc patients meeting the Dutch Rec-
ommendation for Health-Enhancing PA are reported in 
Table 2. There was no significant difference in proportion 
of SSc patients meeting the Dutch Recommendation for 
Table 2  Proportions of patients 
and persons from the general 
population meeting Dutch 
Recommendation for Health-
Enhancing Physical Activity 
(%)
The comparisons between the patients with systemic sclerosis and the Dutch population were done with a 
logistic regression relating group (systemic sclerosis or Dutch population) to adherence of the Dutch Rec-
ommendation for Health-Enhancing Physical Activity (yes/no)
NA not applicable, SSc systemic sclerosis
Patients with 
SSc (N = 59)
Dutch population (N = 5789) Odds ratio Dutch population vs. 
SSc (95% confidence interval)
p value
Total
 < 55 57% (N = 8) 51% (N = 1609/3142) 0.787 (0.273–2.274) 0.658
 ≥ 55 71% (N = 32) 72% (N = 1919/2647) 1.071 (0.559–2.052) 0.836
 All 68% (N = 40) 61% (N = 3528/5789) 0.983 (0.561–1.721) 0.951
Women
 < 55 57% (N = 8) 51% (N = 909/1769) 0.793 (0.274–2.294) 0.668
 ≥ 55 71% (N = 27) 69% (N = 920/1333) 0.908 (0.446–1.847) 0.789
 All 67% (N = 35) 59% (N = 1829/3102) 0.870 (0.481–1.575) 0.645
Men
 < 55 – 51% (N = 700/1373) NA NA
 ≥ 55 71% (N = 5) 76% (N = 999/1314) 1.269 (0.245–6.6571) 0.777
 All 71% (N = 5) 63% (N = 1699/2687) NA NA
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Health-Enhancing PA as compared to the Dutch population 
(68 vs. 61%; P = 0.951).
Subgroup analyses according to age and gender showed 
that the proportion of male SSc patients fulfilling the Dutch 
Recommendation for Health-Enhancing PA was lower than 
the male Dutch population (71 vs. 76%; P = 0.777). Both 
the proportions of female SSc patients aged younger than 
55 years and aged 55 years older and fulfilling the recom-
mendations for PA were higher than the Dutch popula-
tion (respectively 57 vs. 51%, P = 0.668 and 71 vs. 69%, 
P = 0.789). Stratification for BMI (BMI < 25 vs. BMI ≥ 25) 
did not show a difference in the proportion of patients fulfill-
ing the Dutch Recommendation for Health-Enhancing PA.
Excluding the SSc patient with significant comorbid-
ity other than SSc and possibly interfering with PA, these 
results did not change.
Time spent on PA in patients with SSc and the Dutch 
population
Table 3 describes the minutes per week spent on PA in 
patients with SSc and the general population. Regarding the 
total minutes spent on PA, SSc patients were significantly 
less physically active than the Dutch population (1704 vs. 
2614 min/week, P < 0.001; relative difference 35%).
Male SSc patients aged 55 years and older, as well as 
female SSc patients aged 55 years and younger, spent sig-
nificantly less minutes on PA per week than their male and 
female controls from the Dutch population (respectively 818 
vs. 2065 min/week with P < 0.001 and 1944 vs. 2951 min/
week with P = 0.001).
When splitting the total PA into different categories, SSc 
patients generally spent less minutes per week on the major-
ity of different activities than the Dutch population, except 
household activities in the total group (785 vs. 745 min/
week, P = 0.492.
Stratified for gender, female SSc patients aged 55 years 
and younger spent significantly less minutes per week than 
the female Dutch population on total activities (1944 vs. 
2951 min/week, P = 0.001), commuting (57 vs. 123 min/
week, P = 0.002) and household activities (620 vs. 1027 min/
week, P = 0.003). The female SSc patients aged 55 years and 
older spent significantly less minutes on working or school 
activities (258 vs. 376 min/week, P < 0.001). The male SSc 
patients aged 55 years and older spent significantly less 
minutes per week than the male Dutch population on total 
activities (818 vs. 2065 min/week, P < 0.001), working or 
school activities (1 vs. 672 min/week, P < 0.001), commut-
ing (0 vs. 76 min/week, P < 0.001), leisure time activities 
(572 vs. 848 min/week, P = 0.037) and sporting activities 
(56 vs. 121 min/week, P < 0.001).
Excluding the patient with severe comorbidity other 
than SSc and possibly interfering with PA, two categories 
of physical activities changed for SSc patients. First, 
excluding this patient, SSc patients performed 514 min per 
week on leisure time activities; 7 min less without exclud-
ing this SSc patient. Excluding this patient, the compari-
son of leisure time activities between the SSc patients and 
the Dutch population is no longer significant (P = 0.070). 
Second, excluding this SSc patient with comorbidity, 
female SSc patients aged 55 years and older performed 
265 min per week on working or school activities; 7 min 
more than without excluding this patient. Excluding this 
SSc patient, the comparison of working or school activities 
between the female SSc patients aged 55 years and older 
and the female Dutch population aged 55 years and older 
is no longer significant (P = 0.281).
Table 3  Minutes per week spent on physical activity
All p values < 0.05 are considered significant and shown in italics
SSc systemic sclerosis patients, DP Dutch population
* The analysis to compare the amount of minutes per week spent on 
physical activity between the patients with systemic sclerosis and the 
Dutch population was done with a t test
a Numbers represent the number of SSc patients in each group
Total Women Men
(N = 59)a < 55 ≥ 55 ≥ 55
(N = 14)a (N = 38)a (N = 7)a
Total activities (min/week), mean (SD)
 SSc 1704 (1013) 1944 (1176) 1778 (939) 818 (637)
 DP 2614 (1422) 2951 (1280) 2015 (1423) 2065 (1460)
 p value* < 0.001 0.001 0.131 < 0.001
Working or school activities (min/week), mean (SD)
 SSc 363 (711) 827 (931) 258 (608) 1 (4)
 DP 1162 (1097) 1312 (919) 376 (720) 672 (1023)
 p value* < 0.001 0.052 < 0.001 < 0.001
Commuting (min/week), mean (SD)
 SSc 48 (132) 57 (78) 54 (157) 0 (0)
 DP 93 (257) 123 (258) 47 (198) 76 (278)
 p value 0.010 0.002 0.788 < 0.001
Household activities (min/week), mean (SD)
 SSc 785 (609) 620 (508) 945 (596) 244 (516)
 DP 745 (799) 1027 (928) 1012 (858) 474 (592)
 p value* 0.617 0.003 0.501 0.240
Leisure time activities (min/week), mean (SD)
 SSc 507 (425) 440 (355) 534 (464) 572 (345)
 DP 617 (639) 520 (466) 440 (355) 848 (812)
 p value* 0.049 0.579 0.367 0.037
Sport (min/week), mean (SD)
 SSc 87 (115) 108 (74) 88 (135) 56 (50)
 DP 141 (257) 86 (134) 108 (74) 131 (294)
 p value* < 0.001 0.460 0.858 < 0.001
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SSc patients’ needs, preferences and perceptions 
regarding PA promotion and guidance related 
to exercise
Table 4 shows the needs, preferences and perceptions regard-
ing PA promotion and guidance related to exercise of the 
SSc patients. Thirty seven (66%) patients were satisfied with 
their current physical activities, whereas 19 (34%) patients 
wanted to be more physically active. Fourteen (22%) SSc 
patients wished to have additional instructions related to PA 
and exercise. Of those 13 patients, eight patients wanted to 
receive guidance on a weekly basis and two patients accord-
ing to their need. Furthermore, nine of those 13 patients 
who wanted additional instructions related to PA and exer-
cise, wished to receive individual instructions for general or 
specific physical therapy (N = 1 and N = 3) or both (N = 5), 
and six patients wished to have instructions in groups. Con-
cerning group instructions, one patient wanted to have these 
at the gym, one together with other SSc patients, one with 
patients with a rheumatic disease and two patients a combi-
nation of these previous options.
Forty-three (80%) SSc patients indicated that they 
thought PA can have beneficial effects on their health status 
and that being physically active is not harmful. Nevertheless, 
39 (66%) SSc patients stated that they needed additional 
information about exercise and sports, occupational therapy 
and physical therapy. One-third of the SSc patients reported 
to rely on advice of their rheumatologist and general practi-
tioner with regard to advice on PA and exercise.
Furthermore, 18 SSc patients (32%) stated to suffer 
from a lot of pain due to PA including sports. SSc patients 
who did not meet the Dutch Recommendation for Health-
Enhancing PA more often reported to suffer from pain due 
to PA compared to SSc patients who did meet the Dutch 
Recommendation for Health-Enhancing PA (9/18 [50%] vs. 
9/38 [24%], P = 0.049). Sixteen (27%) SSc patients stated 
that lack of energy interfered with being active. SSc patients 
who did not meet the Dutch Recommendation for Health-
Enhancing PA more often reported a lack of energy inter-
fering with PA than SSc patients who did meet the Dutch 
Recommendation for Health-Enhancing PA (10/19 [53%] 
vs. 6/40 [15%], P = 0.002).
Disease characteristics associated with PA levels 
in SSc patients
As shown in Table 5, univariate analyses of patient charac-
teristics demonstrated that age, gender, proximal muscular 
Table 4  Perceptions of systemic sclerosis patients regarding physical activity promotion and guidance related to exercise
Missing numbers not listed
Answers were collected on a Likert scale and then transformed in dichotomous outcomes (agree or highly agree = 1, highly disagree, disagree or 
indifferent = 0)
a Patients could choose multiple options
Agreed or highly 
agreed, N (%)
I am satisfied with my current level of physical activities 37 (66%)
I need guidance to PA and/or exercise 13 (23%)
 I would like to have guidance once a  weeka 8/13 (62%)
 I would like to have guidance when I need  ita 2/13 (15%)
 I would like to have guidance  individuallya 9/13 (69%)
 I would like to have guidance in  groupsa 6/13 (46%)
I need more information about physical activity and sports, physical therapy, or physical therapists with specific knowledge 
and skills regarding the management of systemic sclerosis
39 (68%)
Patients with systemic sclerosis
 Have their own responsibility to be sufficiently physically active 54 (92%)
 Rely on advice of their rheumatologists and general practitioners regarding PA and exercise 17 (29%)
The type of PA (including exercise and sports) I would prefer
 Is not appropriate for people with a disease such as systemic sclerosis 10 (19%)
 Could damage my joints, lungs, heart or skin 9 (16%)
After being physically I get a lot of pain 18 (32%)
In generally, I do not
 Have enough energy to engage in exercise or sports 16 (27%)
 Have enough time to engage in exercise play sports 5 (9%)
 Want to engage in exercise or play sports 10 (17%)
Sufficient levels of physical activity have a beneficial effect on the health status of persons with systemic sclerosis 48 (81%)
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weakness and synovitis, interstitial lung disease, the SHAQ, 
pain during exercising and a lack of energy were associated 
with total minutes of PA per week (P < 0.2). For example, 
a male SSc patient spent 1005 min per week less on PA 
than female SSc patients. Multivariable analysis showed that 
male gender, the SHAQ and a lack of energy were the factors 
significantly associated with the amount of minutes spent 
on PA in the SSc group (respectively P = 0.007, P = 0.042 
and P = 0.025).
Excluding the SSc patient with significant comorbid-
ity other than SSc and possibly interfering with PA, these 
results did not change.
Discussion
To the best of our knowledge, this is the first study that 
evaluated levels of physical activity (PA) in SSc patients 
and compared these levels to the general Dutch popula-
tion. Our data show that, stratified for age and gender, the 
proportions of SSc patients meeting the Dutch Recommen-
dation for Health-Enhancing PA was not significantly dif-
ferent from the Dutch population. However, with respect 
to the mean number of minutes of PA per week, the SSc 
patients were less physically active. In patients not meet-
ing the Dutch Recommendation for Health-Enhancing PA 
pain and lack of energy might interfere with PA. Multivari-
able analysis showed that the male gender, lower functional 
ability as reflected by the SHAQ and a lack of energy were 
associated with lower levels of PA. As PA has been shown 
to be beneficial, these results underline the importance of 
proper guidance of SSc patients regarding a healthy lifestyle 
including appropriate levels of PA. In addition, factors caus-
ing pain and lack of energy should be addressed, as they 
seem to interfere with attaining and maintaining sufficient 
levels of activity. The difference between the proportion of 
patients meeting the Dutch Recommendation for Health-
Enhancing PA on the one hand, and the mean number of 
minutes PA per week on the other hand, shows that solely 
meeting a recommendation is not a reliable way to asses PA. 
No previous study has assessed self-reported levels of PA for 
SSc patients. However, our results are in line with previous 
research in patients with rheumatoid arthritis (RA), where 
the proportion of RA patients meeting the Dutch Recom-
mendation for Health-Enhancing PA was comparable to the 
general population, but the mean number of minutes per 
week spent on PA was lower [9]. Strikingly, SSc patients in 
the current study performed more minutes per week on PA 
than the RA patients (1704 vs. 1535 min/week) in the previ-
ous study [9]. This could possibly be explained by the spe-
cific information and physical therapy that the SSc patients 
in the current study receive as part of their care program. 
Another reason might be that RA is characterised by syno-
vitis and joint complaints, while in SSc specific joint prob-
lems are less frequent (10% of the included SSc patients had 
proximal muscular weakness or synovitis). However, data 
on joint involvement in the RA study are lacking. Another 
explanation could be that the study in RA patients was per-
formed over 10 years ago. Currently, the proportion of per-
sons meeting the public health recommendation for healthy 
PA has increased in general in the Netherlands [30].
Regarding the relevance of our findings, it is plausi-
ble that, like in patients with other rheumatic conditions, 
enhancing PA levels according to levels recommended for 
the general population, including elderly and patients with 
chronic diseases [31], may improve physical functioning 
or prevent deterioration in SSc patients. Beneficial effects 
of PA have been demonstrated in many different diseases 
such as diabetes mellitus type 2 and rheumatoid arthritis 
[32, 33]. Moreover, beneficial outcomes regarding aerobic 
capacity and muscle strength have been reported [5, 34, 35]. 
Indeed, with respect to safety of PA in patients with SSc, 
Table 5  Association between disease characteristics and number of minutes of physical activity
Shown are beta for “yes” of reference category for all categorical variables
a Univariate linear regressions were done relating minutes per week spent on physical activity to individual variables
b Multivariate linear regression analysis included all variables with a P value < 0.2 in the univariate analyses. Only significant outcomes were 
reported
Variables in analysis Univariate  analysesa Multivariate  analysisb
Coefficient 95% confidence interval Coefficient 95% confidence interval
Age − 15 (− 36, 7)
Male gender − 1005 (− 1785, − 225) − 1025 (− 1751, − 298)
Proximal muscular weakness or synovitis − 585 (− 1462, 291)
Interstitial lung disease − 645 (− 1162, 128)
Scleroderma Health Assessment Questionnaire − 492 (− 892, − 93) − 444 (− 830, − 58)
Pain during exercise − 595 (− 1167, − 22)
Lack of energy − 860 (− 1415, − 306) − 571 (− 1121, − 22)
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various studies have demonstrated that exercise programs 
with moderate to even vigorous intensity did not have detri-
mental effects. For example, a multidisciplinary team-care 
program of 12 weeks implying daily and structured exercise 
in a randomized controlled design, resulted in less limita-
tions in activities, and improvement in mouth opening and 
hand grip strength. These improvements were still present 
after 24 weeks but no longer significant, suggesting a need 
for continuous guidance to encourage SSc patients to exer-
cise [35]. These results can, however, not be extrapolated to 
the total population of patients with SSc, as they concern 
selected groups of patients, in whom contra-indications for 
vigorous exercise were ruled out. Given the potential risks 
of high intensity PA in this patient group, regular screening 
of the heart and the lungs by monitoring pulse oximetry and 
heart rate and supervision by health professionals during 
exercise, seems warranted.
Previous literature showed that involvement of the cardio-
pulmonary system can result in a reduced exercise tolerance 
[36–38]. Indeed, interstitial lung disease was associated with 
lower levels of PA in our study in the univariate analysis. 
No other characteristics reflecting severe organ involvement 
like left ventricular ejection fraction and diffuse cutaneous 
SSc, were associated with levels of PA in our study. Vari-
ous explanations might account for this observation. The 
number of included patients is low, resulting in possible lack 
of power to find an association. For example, the wide con-
fidence interval for the association between interstitial lung 
disease and lower levels of PA (− 1162 to 128) supports 
this explanation. Additionally, by including patients visiting 
an information meeting, it is possible that patients with the 
most severe disease activity did not participate. For example, 
only a small portion of patients had a decreased left ven-
tricular ejection fraction (N = 7, 13%), and the proportion of 
anti-centromere positive patients was higher as compared to 
all patients participating in the care program (51 vs. 32%).
In this study, pain during exercise and a lack of energy 
were interfering with exercise. It is, therefore, important 
to determine the reasons behind these two factors because 
solving this might enhance PA. Furthermore, female SSc 
patients spent more time on PA than men. Conclusions 
should be drawn with caution, given the low percentage of 
men included. However, the percentage of men did not differ 
from the total cohort, justifying carefully monitoring PA in 
male patients.
Finally, given that nearly two-third of the SSc patients 
wanted to receive more information concerning PA pro-
motion and guidance related to exercise and therapy and 
roughly one-third reported to rely on the advice of their 
rheumatologist or general practitioner, health care providers 
should be aware of these expectations among their patients.
This study has some limitations that should be taken into 
account. First, data were gathered by means of self-reporting 
questionnaires which could lead to bias. Second, the data 
of the Dutch population were only available on an aggre-
gated level, limiting the possibility of using several statisti-
cal analyses.
In conclusion, in SSc patients, the total minutes of PA 
per week is significantly lower compared to the general 
population. The male gender, functional ability as reflected 
by SHAQ and lack of energy seem to interfere with PA. 
One-third of the SSc patients expressed the need to have 
more information concerning physical activity promotion 
and guidance related to exercise. These results might guide 
health professionals in providing their patients with appro-
priate information on physical activity.
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